Researchers mapped gene enhancers contributing to skull and face development; we’re closer to isolating causes of craniofacial defects like cleft palate.
Blind mole rats’s adaptation to stressors like hypoxia, through modified genes, have enabled them to stave off cancer. Could spalax help people do the same?
Upregulated expression of long non-coding RNAs, PCGEM1 and PRNCR1, in prostate cancer, alters gene expression of androgen receptor’s target genes.
There’s a new type of gene therapy: Suppressing non-coding RNA, or eRNA. is the primary target in treatment of disease-causing genes.